“biotech Firm Pops 677% on Social Anxiety Spray Trial Success”
August 8, 2023
“A beaten down micro-cap biotech company, Vistagen Therapeutics Inc., notched its best day ever, surging by as many as four digits after its experimental nasal spray for social anxiety disorder hit targets in a late-stage trial.
The drug developer’s stock soared a record 1,370% intraday — before paring gains to close up 677% at $13.05, the highest level in over a year. The unexpected success pushed the stock’s market value to $104 million, a level it had been trading below for the better part of a year amid a broad market selloff in risky assets and a prior trial setback…”
https://finance.yahoo.com/news/biotech-firm-vistagen-surges-1-175147101.html